kras mutation and glutathion BRAFV600E in colorectal cancer reduces sensitivity to oxidative stress promotes site-specific metastasis by stimulating glutathione synthesis: Cell Reports Kinetic and Redox Characterization of
Kinetic and Redox Characterization of KRAS G12C Inhibition bioRxiv KRAS G12V mutation selective requirement for ACSS2 in colorectal adenoma formation: Cell Reports What should we know about the 'undruggable' target KRAS? MedChemExpress Targeting KRAS mutant stomach colorectal tumors by disrupting the ERK2 p53 complex ScienceDirect
Pay in 4 interest-free payments of $6.60 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



